NCT01224808 - Extension Study of Biostate in Subjects With Von Willebrand Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions

Von Willebrand Disease

Interventions

BIOLOGICAL

Biostate

Single bolus doses, administered intravenously. Frequency and dose will be determined by the Investigator based on the subjects clinical condition, previous VWF concentrate requirements, response to therapy, weight and reason for usage.

Trial Locations (6)

Unknown

Study Site, Sofia

Study Site, Bremen

Study Site, Warsaw

Study Site, Wroclaw

Study Site, Barnaul

Study Site, Lviv